GT Biopharma (GTBP) Inventory Average (2012 - 2014)
GT Biopharma (GTBP) posted quarterly Inventory Average of $42000.0 for Q1 2014, down 45.1% year-over-year from $76500.0 in Q1 2013, and down 45.1% quarter-over-quarter from $76500.0 in Q1 2013.
GT Biopharma (GTBP) Inventory Average (2012 - 2014) Analysis & Trends
GT Biopharma (GTBP) has reported Inventory Average for 3 consecutive years, with $42000.0 the latest figure, recorded in Q1 2014.
- In Q1 2014, Inventory Average fell 45.1% year-over-year to $42000.0; the TTM figure through Mar 2014 stood at $42000.0 (down 45.1% YoY), while the FY2013 annual figure was $50500.0, up 42.25% from the prior year.
- Inventory Average declined to $42000.0 in Q1 2014 per GTBP's latest filing, from $76500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $76500.0 in Q1 2013 and bottomed at $12000.0 in Q1 2012.
- Historically, Inventory Average has averaged $45625.0 across 3 years, with a median of $47000.0 in 2012.
- Annual changes were most pronounced in 2013 — Inventory Average soared 537.5% — and 2014, when it plunged 45.1%.
- GT Biopharma's Inventory Average stood at $52000.0 in 2012, then surged by 47.12% to $76500.0 in 2013, then plunged by 45.1% to $42000.0 in 2014.
- Business Quant data shows GTBP's Inventory Average at $42000.0 in Q1 2014, $76500.0 in Q1 2013, and $52000.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | GT Biopharma | 8.38 Mn | 8.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 42,000.00 |
| Mar 31, 2013 | 76,500.00 |
| Jun 30, 2012 | 52,000.00 |
| Mar 31, 2012 | 12,000.00 |